Cargando…
Pulmonary toxicity in patients treated with gemcitabine and a combination of gemcitabine and a taxane: investigation of a signal using postmarketing data
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2006
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361299/ https://www.ncbi.nlm.nih.gov/pubmed/16685265 http://dx.doi.org/10.1038/sj.bjc.6603161 |
| _version_ | 1782153182279892992 |
|---|---|
| author | Czarnecki, A Voss, S |
| author_facet | Czarnecki, A Voss, S |
| author_sort | Czarnecki, A |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-2361299 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2006 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-23612992009-09-10 Pulmonary toxicity in patients treated with gemcitabine and a combination of gemcitabine and a taxane: investigation of a signal using postmarketing data Czarnecki, A Voss, S Br J Cancer Letter to the Editor Nature Publishing Group 2006-06-05 2006-05-09 /pmc/articles/PMC2361299/ /pubmed/16685265 http://dx.doi.org/10.1038/sj.bjc.6603161 Text en Copyright © 2006 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Letter to the Editor Czarnecki, A Voss, S Pulmonary toxicity in patients treated with gemcitabine and a combination of gemcitabine and a taxane: investigation of a signal using postmarketing data |
| title | Pulmonary toxicity in patients treated with gemcitabine and a combination of gemcitabine and a taxane: investigation of a signal using postmarketing data |
| title_full | Pulmonary toxicity in patients treated with gemcitabine and a combination of gemcitabine and a taxane: investigation of a signal using postmarketing data |
| title_fullStr | Pulmonary toxicity in patients treated with gemcitabine and a combination of gemcitabine and a taxane: investigation of a signal using postmarketing data |
| title_full_unstemmed | Pulmonary toxicity in patients treated with gemcitabine and a combination of gemcitabine and a taxane: investigation of a signal using postmarketing data |
| title_short | Pulmonary toxicity in patients treated with gemcitabine and a combination of gemcitabine and a taxane: investigation of a signal using postmarketing data |
| title_sort | pulmonary toxicity in patients treated with gemcitabine and a combination of gemcitabine and a taxane: investigation of a signal using postmarketing data |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361299/ https://www.ncbi.nlm.nih.gov/pubmed/16685265 http://dx.doi.org/10.1038/sj.bjc.6603161 |
| work_keys_str_mv | AT czarneckia pulmonarytoxicityinpatientstreatedwithgemcitabineandacombinationofgemcitabineandataxaneinvestigationofasignalusingpostmarketingdata AT vosss pulmonarytoxicityinpatientstreatedwithgemcitabineandacombinationofgemcitabineandataxaneinvestigationofasignalusingpostmarketingdata |